Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward

@article{Braida2008InvolvementO,
  title={Involvement of $\kappa$-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward},
  author={Daniela Braida and Valeria Limonta and Valeria Capurro and Paola Fadda and Tiziana Rubino and Paola Mascia and Alessia Zani and Enzo Gori and Walter Fratta and Daniela Parolaro and Mariaelvina Sala},
  journal={Biological Psychiatry},
  year={2008},
  volume={63},
  pages={286-292}
}

Figures from this paper

Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats
TLDR
These findings support previous reports indicating that the discriminative stimulus effects of salvinorin A are mediated by kappa receptors, and future studies may assist in the development and screening of salvinegorin A analogs for potential pharmacotherapy.
Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal Fluid
TLDR
These are the first studies documenting rapid unconditioned effects of salvinorin A in a primate species, consistent with descriptive reports of rapid and robust effects of this powerful hallucinogen in humans.
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents
TLDR
These findings suggest that similarities in the pharmacological effects of salvinorin A and those of cannabinoids are mediated by its activation of KOR rather than by any direct action of salvia divinorum A on the endocannabinoid system.
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat
TLDR
Salvinorin A differs from other commonly abused compounds since although it affects accumbal dopamine transmission, yet it is unable, at least at the tested doses, to sustain stable intravenous self-administration behaviour.
Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo
TLDR
It is concluded that salvinorin A—via KORs and CB1 receptors—exerts ultrapotent actions on macrophages and also shows moderate antinflammatory effects in vivo.
Learning and Memory Impairment Induced by Salvinorin A, the Principal Ingredient of Salvia divinorum, in Wistar Rats
TLDR
It is demonstrated for the first time that salvinorin A has deleterious effects on learning and memory, through a κ-opioid receptor mechanism.
Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.
Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
TLDR
Salvinorin A has therapeutic potential as a treatment for pain, mood and personality disorders, substance abuse, and gastrointestinal disturbances, and suggests that nonalkaloids are potential scaffolds for drug development for aminergic G-protein coupled receptors.
A single injection of a novel kappa opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats
TLDR
It is indicated that Sal A, just like traditional KOPr agonists, attenuates cocaine-induced behavioral sensitization but does not produce the adverse effect of conditioned aversion, suggesting improved potential compliance.
...
...

References

SHOWING 1-10 OF 50 REFERENCES
Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement
TLDR
Results indicate that salvinorin A, as is sometimes reported in humans, exhibits rewarding effects, independently from its motor activity, suggesting the usefulness of the zebrafish model to study addictive behavior.
Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats
TLDR
SalvA data provide additional support for the hypothesis that stimulation of brain κ-opioid receptors triggers depressive-like signs in rats and raise the possibility that decreases in extracellular concentrations of DA within the NAc contribute to these effects.
Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse
TLDR
In the mouse, salvinorin A disrupted climbing behavior on an inverted screen task, indicating a rapid, but short-lived induction of sedation/motor incoordination and the possibility that the development of other diterpene-based opioids may yield important therapeutic compounds.
The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys
TLDR
The naturally occurring hallucinogen salvinorin A produces discriminative stimulus effects similar to those of a high efficacy κ-agonist in non-human primates.
Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors
TLDR
The inhibitory effect of salvinorin A on striatal dopamine levels may contribute to its induction of conditioned place aversion and decreases in locomotion in mice.
Antinociceptive and Hypothermic Effects of Salvinorin A Are Abolished in a Novel Strain of κ-Opioid Receptor-1 Knockout Mice
TLDR
It is demonstrated that salvinorin A is the active component of S. divinorum, selective for κ1-opioid receptors, and that salvinegorin A and specific structurally related analogs produce behavioral effects that require the κ-opIOid receptor.
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
  • B. Roth, K. Baner, R. Rothman
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2002
TLDR
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for κ opioid receptors and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
  • B. Roth, K. Baner, R. Rothman
  • Biology, Psychology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2002
TLDR
Salvinorin A is the first naturally occurring nonnitrogenous opioid-receptor subtype-selective agonist for kappa opioid receptors, and may represent novel psychotherapeutic compounds for diseases manifested by perceptual distortions (e.g., schizophrenia, dementia, and bipolar disorders).
...
...